Scott G Franzblau

24PUBLICATIONS
71CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designGene and molecular therapyGlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 26, 2026
Biological Evaluation of Esters of 4-Carboxylate-1,2,3-triazine and Analogs as New Potential Anti-Mycobacterium tuberculosis Agents.

|Dec 12, 2025
Unique Interactions of Novel Rufomycin "Click Chemistry" Analogs with Mtb ClpC1 and Implications.

Kiira Ratia, Shengnan Jin, Celerino Abad-Zapatero

|Dec 03, 2025
Selectivity of the Time-Dependent M. tuberculosis LeuRS Inhibitor Ganfeborole Is Driven by Target Vulnerability.

Mingqian Wang, YongLe He, Siobhan A Cohen

|Mar 24, 2025
Structure-Based Analysis of Semisynthetic Anti-TB Rufomycin Analogues.

Bin Zhou, Gauri Shetye, Larry L Klein

|Feb 14, 2025
Expanding the Landscape of Dual Action Antifolate Antibacterials through 2,4-Diamino-1,6-dihydro-1,3,5-triazines.

John D Georgiades, Daniel A Berkovich, Samuel R McKee

|Nov 11, 2024
Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls Club.

Jin Yi Tan, Mario Augustinović, Ashraf M Omar

Pageof 4

Frequent Collaborators

9 joint publications

Guido Pauli

7 joint publications

James McAlpine

7 joint publications

Sanghyun Cho

4 joint publications

Shao-Nong Chen